38112003: 1 (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

64719019 One en Synonym Active Entire term case insensitive SNOMED CT core module

3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module

3442105014 1 en Synonym Active Entire term case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
1	Is a	General adjectival modifier	false	Inferred relationship	Existential restriction modifier
1	Is a	Number	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely sodium fluoride 1.1 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely sorafenib (as sorafenib tosylate) 200 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely tipranavir 250 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely piroxicam 20 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely oxycodone hydrochloride 80 milligram/1 each prolonged-release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely ferrous fumarate 305 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely miglustat 100 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely paracetamol 240 milligram/1 each conventional release rectal suppository	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely vardenafil hydrochloride 10 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely treosulfan 250 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely doxylamine 25 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely solifenacin succinate 10 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely warfarin sodium 2 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely milnacipran hydrochloride 12.5 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely paracetamol 325 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely efavirenz 50 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely lithium carbonate 250 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely everolimus 500 microgram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely risperidone 6 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely ruxolitinib 15 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely thiamine hydrochloride 50 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely milnacipran hydrochloride 25 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely methysergide (as methysergide maleate) 1 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely morphine sulfate 150 milligram/1 each prolonged-release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely theophylline anhydrous 300 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely midodrine hydrochloride 2.5 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely nicorandil 20 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely tacrolimus 500 microgram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely methylphenobarbital 50 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely perphenazine 4 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely phentermine hydrochloride 37.5 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely nitazoxanide 500 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely phenylbutazone 200 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely galantamine (as galantamine hydrobromide) 8 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely famotidine 20 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely pyridostigmine 30 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely frovatriptan succinate 2.5 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely sulfafurazole 500 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely sodium fluoride 2.21 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely estazolam 1 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely morphine sulfate 5 milligram/1 each prolonged-release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely venlafaxine hydrochloride 100 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely oxybutynin hydrochloride 5 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely simvastatin 5 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely mefenamic acid 250 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely methylthioninium chloride 65 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely glycopyrronium bromide 1 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely solifenacin succinate 5 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely rivastigmine (as rivastigmine tartrate) 1.5 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely paracetamol 650 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely prasugrel 10 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely efavirenz 100 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely tedizolid phosphate 200 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely everolimus 750 microgram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely ruxolitinib 25 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely pregabalin 25 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely terazosin 10 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely morphine sulfate 50 milligram/1 each prolonged-release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely pilocarpine 7.5 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely hydroflumethiazide 50 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely morphine sulfate 200 milligram/1 each prolonged-release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely fluoride 1.1 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely minocycline 50 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely ursodeoxycholic acid 150 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely mycophenolate mofetil 250 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely tadalafil 5 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely pimozide 1 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely famotidine 40 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely doxazosin (as doxazosin mesilate) 4 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely valproic acid (as valproate semisodium) 250 milligram/1 each gastro-resistant oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely disopyramide (as disopyramide phosphate) 250 milligram/1 each prolonged-release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely rosiglitazone (as rosiglitazone maleate) 8 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely estazolam 2 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely sodium fluoride 2.2 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely hydromorphone hydrochloride 1.3 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely lisdexamfetamine dimesylate 20 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely doxazosin (as doxazosin mesilate) 8 milligram/1 each prolonged-release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely tetrabenazine 12.5 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely lithium carbonate 400 milligram/1 each prolonged-release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely zinc 25 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely sodium fluoride 500 microgram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely finasteride 5 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely paracetamol 120 milligram/1 each conventional release rectal suppository	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely lovastatin 10 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely tioguanine 40 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely sibutramine hydrochloride monohydrate 5 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely efavirenz 200 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely fluvoxamine maleate 25 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely pregabalin 300 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely fingolimod 500 microgram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely vigabatrin 500 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely tramadol hydrochloride 50 milligram/1 each prolonged-release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely theophylline anhydrous 400 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely fluoride 2.2 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely minocycline 100 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely ursodeoxycholic acid 250 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier

Start Previous Page 54 of 342 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
64719019	One	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module
3442104013	1 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module
3442105014	1	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module